HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard A Burris Selected Research

Carcinoma (Carcinomatosis)

12/2021Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer.
1/2020Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
4/2018Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study.
1/2018Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
8/2017A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.
1/2017Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
5/2016Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
4/2013Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.
5/2010Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
5/2010Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard A Burris Research Topics

Disease

117Neoplasms (Cancer)
01/2024 - 01/2002
66Breast Neoplasms (Breast Cancer)
01/2024 - 01/2002
25Neutropenia
01/2023 - 05/2003
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2005
17Disease Progression
05/2024 - 04/2003
16Thrombocytopenia (Thrombopenia)
10/2019 - 02/2002
16Diarrhea
01/2019 - 05/2003
14Carcinoma (Carcinomatosis)
12/2021 - 03/2002
13Fatigue
01/2019 - 12/2007
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 05/2002
10Nausea
01/2018 - 11/2005
9Vomiting
01/2019 - 11/2005
9Neoplasm Metastasis (Metastasis)
03/2016 - 04/2008
8Exanthema (Rash)
01/2019 - 12/2007
8Febrile Neutropenia
01/2018 - 02/2002
8Colorectal Neoplasms (Colorectal Cancer)
05/2015 - 08/2007
7Anemia
01/2018 - 06/2010
6Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 05/2010
5Mucositis
10/2017 - 05/2009
5Melanoma (Melanoma, Malignant)
03/2016 - 09/2010
4Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 12/2007
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 10/2002
4Infections
01/2018 - 10/2011
4Prostatic Neoplasms (Prostate Cancer)
08/2017 - 03/2007
4Stomatitis
02/2017 - 02/2012
4Fever (Fevers)
01/2017 - 10/2008
4Pancreatic Neoplasms (Pancreatic Cancer)
04/2013 - 03/2005
3Hyperglycemia
01/2024 - 02/2012
3Lymphoma (Lymphomas)
01/2023 - 03/2007
3Pain (Aches)
08/2018 - 09/2015

Drug/Important Bio-Agent (IBA)

26Carboplatin (JM8)FDA LinkGeneric
12/2019 - 03/2002
22Paclitaxel (Taxol)FDA LinkGeneric
08/2017 - 01/2002
21Hormones (Hormone)IBA
12/2023 - 03/2010
21Trastuzumab (Herceptin)FDA Link
10/2023 - 01/2004
18EverolimusFDA Link
12/2023 - 04/2008
18Bevacizumab (Avastin)FDA Link
11/2023 - 12/2007
17GemcitabineFDA Link
05/2024 - 03/2002
14Ado-Trastuzumab EmtansineIBA
11/2019 - 06/2010
14Docetaxel (Taxotere)FDA Link
01/2017 - 05/2005
12ErbB Receptors (EGF Receptor)IBA
10/2023 - 08/2005
11exemestane (Aromasin)FDA Link
12/2023 - 02/2012
11Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 05/2003
10taxaneIBA
11/2019 - 01/2002
9PlatinumIBA
01/2023 - 02/2002
9Aromatase InhibitorsIBA
01/2021 - 02/2012
9Immunoconjugates (Immunoconjugate)IBA
01/2020 - 06/2010
9Pemetrexed (MTA)FDA Link
12/2019 - 01/2010
8Biomarkers (Surrogate Marker)IBA
11/2023 - 08/2013
8human ERBB2 proteinIBA
10/2023 - 02/2011
8Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 12/2007
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 06/2008
7Angiogenesis InhibitorsIBA
11/2023 - 01/2010
7pertuzumabIBA
10/2023 - 09/2012
7Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017 - 06/2008
7ixabepilone (BMS 247550)FDA Link
08/2017 - 03/2007
7Monoclonal AntibodiesIBA
04/2013 - 03/2010
6Epidermal Growth Factor (EGF)IBA
12/2023 - 05/2010
6pegfilgrastim (Neulasta)FDA Link
01/2018 - 06/2008
6Capecitabine (Xeloda)FDA Link
02/2014 - 01/2010
6Lapatinib (GW572016)FDA Link
06/2011 - 01/2004
6Topotecan (Hycamtin)FDA LinkGeneric
05/2011 - 05/2002
5Fulvestrant (Faslodex)FDA Link
01/2024 - 06/2011
5Letrozole (Femara)FDA LinkGeneric
10/2022 - 11/2016
5ribociclibIBA
10/2022 - 11/2016
5Estrogen ReceptorsIBA
01/2020 - 05/2013
5pazopanibFDA Link
01/2018 - 01/2010
5TOR Serine-Threonine KinasesIBA
01/2016 - 04/2008
5Epothilones (Epothilone)IBA
10/2012 - 03/2007
4Immune Checkpoint InhibitorsIBA
05/2024 - 05/2016
4Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2006
4Phosphotransferases (Kinase)IBA
01/2024 - 01/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 06/2011
4rucaparibIBA
01/2023 - 08/2017
4atezolizumabIBA
01/2022 - 11/2014
4Sorafenib (BAY 43-9006)FDA Link
11/2017 - 05/2010
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2017 - 05/2011
4dabrafenibIBA
03/2016 - 11/2012
4trametinibIBA
03/2016 - 08/2012
4AnthracyclinesIBA
12/2014 - 04/2009
4Fluorouracil (Carac)FDA LinkGeneric
07/2012 - 01/2002
4Cetuximab (Erbitux)FDA Link
07/2010 - 08/2007
4Vinorelbine (Navelbine)FDA LinkGeneric
08/2009 - 04/2003
3AlpelisibIBA
01/2024 - 01/2018
3Tyrosine (L-Tyrosine)FDA Link
01/2023 - 01/2004
3AndrogensIBA
01/2022 - 03/2007
3Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 08/2017
3Anastrozole (Arimidex)FDA LinkGeneric
01/2021 - 06/2011
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021 - 11/2016
3Mechanistic Target of Rapamycin Complex 1IBA
11/2020 - 04/2013
3Messenger RNA (mRNA)IBA
12/2019 - 04/2013
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019 - 10/2017

Therapy/Procedure

62Therapeutics
12/2023 - 07/2002
29Drug Therapy (Chemotherapy)
11/2023 - 07/2002
7Radiotherapy
01/2016 - 07/2002
6Neoadjuvant Therapy
11/2015 - 06/2008
4Immunotherapy
11/2023 - 09/2010
4Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 03/2002
4Aftercare (After-Treatment)
01/2016 - 05/2010
3Intravenous Infusions
01/2020 - 11/2010